Novo Nordisk (Ozempic)

1434.507 - 1457.59 David Rosenthal

So any blessing or patent licensing from the Insulin Committee to the Crows and Hagedorn for Denmark is sort of pointless because it's not legally binding in Denmark anyway. But the Insulin Committee says, well, you're really the right people to do this. How about we give you rights for all of Scandinavia? Norway, Sweden, Denmark, you have our official blessing and any rights that you need.